Cameron Clokie is the CEO of Induce Biologics Inc., a company dedicated to discovering innovative solutions for musculoskeletal reconstruction. Clokie began his practice by working with academic dentistry and clinical practices for three decades, receiving his Doctor of Dental surgery in 1985, completing specialty training in 1990, and receiving a PhD in bone regeneration in relation to dental implants from McGill University in 1992.
Before retiring from academics in 2017, Cameron Clokie was named as Head of Oral and Maxillofacial Surgery in 1998 and as Professor of Oral and Maxillofacial Surgery at the University of Toronto. Clokie holds an impressive 25 US and international existing/pending patents, some of which are related to bone healing, a progressively enticing field of research and medicine. Clokie has published numerous scientific articles regarding regenerative medicine, and shares his extensive experience in speaking lectures around the world.
Clokie has established himself as a leading expert on the subject of facial reconstruction and bone regeneration. Clokie’s position has allowed him to perform reconstructive surgery on individuals whose musculoskeletal form have suffered as a result of either disease or injury. Beginning with mostly aesthetic reformations on Bloomberg.com, Clokie’s research and work would potentially serve to benefit revolutionary practical purposes. Elderly individuals suffering from bone deterioration would benefit from Clokie’s extensive work, effectively returning to a younger age and form. Despite its relatively pricey costs, reconstructive jaw surgery could prove to become much more cheaper as research derived from Clokie would allow for the mass production of a protein necessary for musculoskeletal reconstruction.
Clokie’s professional work ultimately serves to benefit mankind. The extensive research, hypotheticals and real life work all serves to push the boundaries of science and medicine. Individuals who are fortunate to have benefited from Clokie’s precision surgery are just the first patients of a new era of regenerative medicine pioneered by Clokie.